School of Medicine
Showing 101-150 of 536 Results
-
Tami Daugherty
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsDr. Daugherty is a transplant Hepatologist with full-time clinical responsibilities. She is particularly interested in the natural course and management of recurrent Hepatitis C after liver transplant, and the effect of immunosuppression on HCV recurrence.
-
Reinhold Dauskardt
Ruth G. and William K. Bowes Professor in the School of Engineering
BioDauskardt and his group have worked extensively on integrating new materials into emerging technologies including thin-film structures for nanoscience and energy technologies, high-performance composite and laminates for aerospace, and on biomaterials and soft tissues in bioengineering. His group has pioneered methods for characterizing adhesion and cohesion of thin films used extensively in device technologies. His research on wound healing has concentrated on establishing a biomechanics framework to quantify the mechanical stresses and biologic responses in healing wounds and define how the mechanical environment affects scar formation. Experimental studies are complimented with a range of multiscale computational capabilities. His research includes interaction with researchers nationally and internationally in academia, industry, and clinical practice.
-
Guido A. Davidzon
Clinical Associate Professor, Radiology - Rad/Nuclear Medicine
BioDr. Guido A. Davidzon is a physician-scientist board-certified in Nuclear Medicine. He is an attending physician in Nuclear Medicine and Molecular Imaging at Stanford Health Care. He graduated with honors from medical school in Argentina and completed an internship at Yale University New-Haven Hospital in Connecticut. He did his residency and was chief resident at Stanford Health Care. He completed a research fellowship in mitochondrial diseases at Columbia University in New York and a U.S. National Library of Medicine-supported Biomedical Informatics fellowship at Massachusetts General Hospital with a Science Master at MIT.
Dr. Davidzon is a Clinical Associate Professor in the Department of Radiology at Stanford University. His clinical specialties include early diagnostic imaging of cancer, coronary artery disease, and dementias using molecular probes, as well as the treatment of cancer for which he employs targeted radiopharmaceutical therapy.
Dr. Davidzon is the Cardiac PET and SPECT program director and the acting Chair of the Radioactive Drug Research and Clinical Radiation Safety Committees. Guido steers clinical efforts in using PET to evaluate cognitive disorders and assess treatment response for patients receiving novel anti-amyloid therapies. He is an active member of the Artificial Intelligence Task Force at the SNMMI and leads research and translational efforts in artificial intelligence and nuclear medicine at Stanford. Dr. Davidzon is the immediate past President of the Northern California Chapter of the SNMMI. -
Jenna Davis
Associate Dean for Integrative Initiatives in Institutes and International Partnerships, Professor of Civil and Environmental Engineering, at the Stanford Doerr School of Sustainability and Higgins-Magid Senior Fellow at the Woods Institute
Current Research and Scholarly InterestsProfessor Davis’ research and teaching deals broadly with the role that water plays in promoting public health and economic development, with particular emphasis on low- and middle-income countries. Her group conducts applied research that utilizes theory and analytical methods from public and environmental health, engineering, microeconomics, and planning. They have conducted field research in more than 20 countries, most recently including Zambia, Bangladesh, and Kenya.
-
Kara Davis
Assistant Professor of Pediatrics (Hematology/Oncology)
Current Research and Scholarly InterestsChildhood cancers can be considered aberrations of normal tissue development. We are interested in understanding childhood cancers through the lens of normal development. Further, individual tumors are composed of heterogeneous cell populations, not all cells being equal in their ability to respond to treatment or to repopulate a tumor. Thus, we take single cell approach to determine populations of clinical relevance.
-
Kiera Davis
Clinical Associate Director, Education & Training & Project Leader, ValleyCare, Med/Stanford Center for Clinical Research
Current Role at StanfordClinical Associate Director, Education & Training
Program Lead, SHC Tri-Valley Program Management Office (PMO) -
Mark M. Davis
Director, Stanford Institute for Immunity, Transplantation and Infection and the Burt and Marion Avery Family Professor
Current Research and Scholarly InterestsMolecular mechanisms of lymphocyte recognition and differentiation; Systems immunology and human immunology; vaccination and infection.
-
Ronald W. Davis
Professor of Biochemistry and of Genetics
Current Research and Scholarly InterestsWe are using Saccharomyces cerevisiae and Human to conduct whole genome analysis projects. The yeast genome sequence has approximately 6,000 genes. We have made a set of haploid and diploid strains (21,000) containing a complete deletion of each gene. In order to facilitate whole genome analysis each deletion is molecularly tagged with a unique 20-mer DNA sequence. This sequence acts as a molecular bar code and makes it easy to identify the presence of each deletion.
-
Seth J. Davis, MD
Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly InterestsDr. Davis’ research interests include novel treatments for post-facial paralysis management, clinical outcomes in revision rhinoplasty and complex nasal reconstruction, and development of global health educational initiatives. He has presented grant funded, award winning research at dozens of conferences both locally and internationally. He has also published in a wide variety of high-impact journals, including Annals of Oncology, The Laryngoscope, and Facial Plastic Surgery & Aesthetic Medicine.
-
Kristen Davis-Lopez
S-SPIRE Project Manager, Stanford-Surgery Policy Improvement Research and Education Center
BioKristen Davis-Lopez, MPH, PMP is the Research Project Manager at the S-SPIRE Center. She has a background in biology as well as public health. She supports multiple principal investigators with their current funded projects as project manager. She leads the Social Science Research Professionals in the S-SPIRE Center and also assists with the grant submission process within the Department of Surgery acting as a liaison with the Research Management Group.
-
Aaron J. Dawes, MD, PhD, FACS, FASCRS
Assistant Professor of Surgery (General Surgery)
BioDr. Dawes is a board-certified, fellowship-trained colon and rectal surgeon. He is also an Assistant Professor in the Department of Surgery, Division of General Surgery at Stanford University School of Medicine.
Dr. Dawes treats a wide variety of conditions involving the colon, rectum, and anus, always leveraging the latest evidence and technologies. He is fully trained in minimally invasive surgical techniques--including laparoscopic, robotic, and trans-anal minimally invasive surgery--and strives to employ them, whenever possible, in an effort to reduce pain and shorten recovery.
In addition to his clinical work, Dr. Dawes is a health services researcher, receiving his Ph.D. in Health Policy and Management from the UCLA Fielding School of Public Health. His research focuses on policy development, measurement, and evaluation for patients with colorectal conditions. He is particularly interested in using data to drive policy interventions aimed at reducing disparities in quality, access, and value.
Prior to joining Stanford, Dr. Dawes completed a residency in General Surgery at the University of California, Los Angeles followed by a fellowship in Colon and Rectal Surgery at the University of Minnesota. He has authored articles in the Journal of the American Medical Association (JAMA), Cancer, Diseases of the Colon and Rectum, Health Services Research, and JAMA Surgery. His work has also been featured in the Los Angeles Times, the Daily Press, and HealthDay News.
A native of the San Francisco Bay Area, Dr. Dawes received his A.B. in Public and International Affairs from Princeton University and his M.D. from Vanderbilt University. -
Heather Sydney Day
Biostatistician 1, Stanford-Surgery Policy Improvement Research and Education Center
Current Role at StanfordBiostatistician 1, Stanford-Surgery Policy Improvement Research and Education Center
-
John W. Day, MD, PhD
Professor of Neurology (Adult Neurology), of Pediatrics (Genetics) and, by courtesy, of Pathology
On Partial Leave from 03/15/2024 To 06/15/2024Current Research and Scholarly InterestsOur Neuromuscular Division coordinates a comprehensive effort to conquer peripheral nerve and muscle disorders, including the muscular dystrophies, motor neuron disorders, neuromuscular junction abnormalities, and peripheral neuropathies. With patients and families foremost in mind, we have had success defining and combating these diseases, with research focused on identifying genetic causes, developing novel treatment, and maximizing patient function by optimizing current management.
-
John Robert Dayton
Clinical Assistant Professor, Emergency Medicine
BioDr. Dayton was the inaugural Medical Design and Innovation Fellow with Stanford's Department of Emergency Medicine. He also completed a Biodesign Faculty Fellowship with the Byers Center for Biodesign before joining the faculty as an Assistant Professor.
In addition to practicing medicine, he co-founded the Stanford Emergency Medicine Partnership Program (STEPP), works on the Digital Health team, and is involved with producing the annual Stanford Emergency Medicine Innovation Symposium (StEMIX).
Outside of Stanford, Dr. Dayton advises health-tech companies on strategy and physician user experience and works in VC. He co-founded Utah's Society of Physician Entrepreneurs and has served in both state and national leadership positions with the American College of Emergency Physicians (ACEP).
John's areas of expertise include digital therapeutics, AI operational tools, medical devices, clinical validation, academic-private pilot partnerships, and venture funding. -
Thiago Almeida Pereira
Instructor, Institute for Stem Cell Biology and Regenerative Medicine
Current Research and Scholarly InterestsMy research focus on fibrosis pathogenesis, identifying key pathways for therapeutic intervention and biomarker discovery. I'm currently investigating the Hedgehog pathway in liver and lung fibrotic diseases, such as schistosomiasis mansoni, alcoholic and non-alcoholic fatty liver disease, viral hepatitis B and C, idiopathic pulmonary fibrosis. I'm also investigating the role of tumor associated macrophages and cancer associated fibroblasts in liver and head and neck cancers.
-
Aglaia Kaissa de Boer
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioKaïssa de Boer, MD is a board certified pulmonologist who specializes in the care of patients with interstitial lung disease. She completed her Internal Medicine and Pulmonary training at the University of Ottawa, Ottawa, Canada where her initial interest in caring for patients with fibrotic lung disease first developed. Subsequently she completed a fellowship in Interstitial Lung Disease at the University of California, San Francisco under the direction of Dr. Harold Collard. Dr. de Boer has a special interest in patients with connective tissue disease associated lung disease and those with drug induced pneumonitis. In addition she is actively involved in the ILD training and program development of Stanford's Pulmonary Allergy and Critical Care Fellows.
-
Walter De Brouwer
Adjunct Professor, Primary Care and Population Health
BioWalter A. De Brouwer, Ph.D., is an Adjunct Professor at the Stanford School of Medicine. As a core faculty member at CERC DICE, he is the course director for “Innovation in Healthcare: from idea to incorporation,” which includes a bi-weekly presentation. He also serves on the advisory committee focused on the strategic direction for the program and is part of the leadership team developing the program curriculum and practicum. He is the founder of doc.ai, a Palo-Alto-based Federated Edge Learning company for the payers/pharma industry which merged in January 2020 with Sharecare Inc.
Professional Education
Bachelor’s degree in Philology (University of Ghent, Belgium)
Master’s degree in Formal Linguistics (University of Ghent, Belgium)
Post-graduate: Epistemology (University of Ghent, Belgium)
Ph.D. Computational Semiotics (Catholic University of Tilburg, the Netherlands). -
Korina De Bruyne
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsThe EMPOWER study (PI: Dr Beth Darnall) is looking at how to best support patients with chronic pain on long-term opioid therapy through a slow taper (maximal duration of 1 year). Patients are randomized to taper only versus taper plus community-based pain self-management group sessions versus taper plus psychologist-led cognitive behavioral therapy for pain group sessions. Along the way alternative measures to control pain are also explored. Enrollment is open until 10/2021.
-
Bruna de Freitas Dias
Postdoctoral Scholar, Psychiatry
BioI am a Brazilian physician and neuroscientist with a special interest in autoimmune neurological diseases. I graduated from Albert Einstein Medical School, Sao Paulo – Brazil in 2021. My research predominantly focuses on studying the epidemiology of autoimmune encephalitis and genetic susceptibility to the disease onset. Furthermore, I am interested in assessing the burden of the disease in those patients, socioeconomic analysis, and environmental and infectious triggers for the disease onset. At Mignot’s Lab, I am involved in IGNITE project, and I am working in the association of clinical and epidemiological data, KIR sequencing, and GWAS analysis.
My interests include general neurology, neuroimmunology, neuroscience, healthcare, and technology. -
Sallie De Golia
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. De Golia specializes in the treatment of mood and anxiety disorders with an expertise in time-limited dynamic psychotherapy. She is Section Chief of the Assessment Clinics and Director of the Evaluation Clinic. Dr. De Golia is the Residency Director of the Adult Psychiatry Residency Program where she has been involved in overall program management, educational programming, curricular development and mentorship of a residency program involving 52 residents. She is a Peer Teaching Coach and Fellow in the Stanford Teaching and Mentoring Academy, has taught regularly with the Stanford Center for Faculty Development, and is a Senior Fellow at Stanford's Center for Innovation in Global Health. She currently serves on the Executive Committee of the American Association of Directors of Psychiatry Residency Training.
-
Michelle de Haaff
Casual - Non-Exempt, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordAssistant Director of Digital Health
Co-Instructor Biodesign for Digital Health (Fall) and Biodesign for Societal Health (Winter)
Stanford Byers Center for Biodesign -
Vinicio de Jesus Perez MD
Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsMy work is aimed at understanding the molecular mechanisms involved in the development and progression of pulmonary arterial hypertension (PAH). I am interested in understanding the role that the BMP and Wnt pathways play in regulating functions of pulmonary endothelial and smooth muscle cells both in health and disease.
-
Francisco M. De La Vega
Adjunct Professor, Biomedical Data Science
BioFrancisco De La Vega is a distinguished geneticist and computational biologist, and an experienced technical executive, widely recognized for his expertise in clinical and population genomics, and bioinformatics. Currently serving as the Vice President of Hereditary Disease at Tempus Labs, Francisco is spearheading the development of comprehensive germline genetic tests and conducting innovative research into racial disparities in cancer leveraging Tempus’ multimodal Real-World Data. His work focuses on uncovering the connections between genetic ancestry and cancer genome mutational profiles that may help explain the differences in cancer incidence and outcomes across races and ethnicities. In addition to his role at Tempus Labs, Francisco is an Adjunct Professor in the Department of Biomedical Data Science at Stanford University School of Medicine and is a member of the Board of Directors of the International Society of Computational Biology, serving from 2022 to 2025.
Francisco teaches BIODS-235: "Best practices for developing data science software for clinical and healthcare applications" every Winter quarter. -
Adam de la Zerda
Associate Professor of Structural Biology and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsMolecular imaging technologies for studying cancer biology in vivo
